Fulgent Pharma LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2011-06-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.fulgentpharma.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Study of FID-022 in Participants with Advanced Solid Tumors
- First Posted Date
- 2024-11-19
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Fulgent Pharma LLC.
- Target Recruit Count
- 24
- Registration Number
- NCT06694480
FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Fulgent Pharma LLC.
- Target Recruit Count
- 46
- Registration Number
- NCT06332092
- Locations
- 🇺🇸
Highlands Oncology - North Hills, Fayetteville, Arkansas, United States
🇺🇸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸Moffitt Cancer Center Magnolia Campus, Tampa, Florida, United States
News
No news found